Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples